Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
| |
 |
Articles |
|
|
Fill and Finish in Clinical Development: Getting it Right from the Start.
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including any subsequent scale-up steps. ...
|
|
 |
|
|
| |
| |
|
|
Redefining interoperability in the digital age.
The COVID-19 pandemic accelerated this ability making telehealth mainstream for most medical specialties. These shifts and advancements have also stretched the concept of interoperability...
|
|
| |
|
Latest News & Press Releases |
|
|
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19.
Cipla, Dr. Reddy's, Emcure Pharma, Sun Pharma and Torrent Pharmaceuticals Limited, announced that the five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir...
|
|
 |
|
| | |
|
| |
| |
|
|
CluePoints Launch Post-COVID Trial Assurance Solution.
CluePoints has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and, CROs....
|
|
|
| |
|
Emirates SkyCargo to integrate Envirotainer Releye RLP container into its cool chain portfolio.
Envirotainer announced that Emirates SkyCargo, the freight division of Dubai-based Emirates airline, has approved the use of the Environtainer Releye...
|
|
 |
|
| | |
|
| |
| |
|
|
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India.
Moderna, Inc announced that the government of India has issued a registration certificate and a permission to import the COVID-19 Vaccine Moderna...
|
|
|
| |
|
RedHill Biopharmas opaganib shows activity against Covid-19 variants.
RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib, could block Covid-19 variants of concern....
|
|
 |
|
|
| |
| |
|
|
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility.
Clover biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening...
|
|
|
